Women welcome Singapore's move to subsidise genetic testing for hereditary breast and ovarian cancer and cover preventive surgery. Read more at straitstimes.com. Read more at straitstimes.com.

Pfizer Inc. (NYSE:PFE) announced that its Phase 3 TALAPRO-3 clinical trial met its primary endpoint, demonstrating that the combination of TALZENNA (talazoparib) and XTANDI (enzalutamide) ...

The wealthy donors on the Chronicle’s list gave to nonprofits they know and trust.

The FDA approved this combination tablet in the same population late last year based on the AMPLITUDE study data.

During National Cancer Prevention Month, a Los Angeles man explains why genetic testing for BRCA and other mutations matters for men and how action saves lives. Cunaplus_M.Faba Getty Images For most ...

October is National Breast Cancer Awareness Month. While we know that Black women are 40% more likely to die from the disease, Black men are at risk as well, as they have a 52% higher risk of ...

Rubraca is now FDA-approved for BRCA mutation-associated mCRPC after prior androgen receptor-directed therapy, confirming its efficacy in the TRITON3 trial. The TRITON3 trial showed Rubraca ...

SAN ANTONIO – Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited mutations in the BRCA1 or BRCA2 genes, according to the results ...

Experts at The Institute of Cancer Research, London, have responded to the draft recommendation from the National Screening Committee (NSC) to implement a targeted prostate cancer screening programme ...

FORMS, AND YOU MAY HAVE HEARD OF SOME GENE MUTATIONS LIKE BRCA1 OR BRCA2, BUT THERE’S ANOTHER ONE THAT YOU MAY NOT HAVE HEARD OF, AND IT’S CHEK2. MERCY MEDICAL CENTER DOCTOR NEIL FRIEDMAN JOINS US NOW ...